Scott Gottlieb's nomination as the next FDA commissioner is garnering support from industry, but it's generating some opposition from other quarters. A few lawmakers and Public Citizen, a watchdog group, were among the first to express concern about the nomination, citing Gottlieb's connections to industry and his "deregulatory approach." Read More